Depiction of Prostate Cancer Treatment Alternatives in Greece
|ClinicalTrials.gov Identifier: NCT00733213|
Recruitment Status : Completed
First Posted : August 12, 2008
Last Update Posted : October 14, 2009
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
- Target Group: Patients with locally advanced or metastatic prostate cancer.
- The first 10 consecutive patients records that meet the entry criteria.
|Condition or disease|
|Locally Advanced or Metastatic Prostate Cancer.|
|Study Type :||Observational|
|Estimated Enrollment :||310 participants|
|Official Title:||Depiction of Prostate Cancer Treatment Alternatives in Greece|
|Study Start Date :||January 2008|
|Actual Study Completion Date :||March 2009|
- Percentage of patients treated by each treatment alternative. [ Time Frame: Between 2002 - 2008 ]
- To depict sociodemographic characteristics and comorbidities. [ Time Frame: Between 2002 - 2008 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00733213
|Study Director:||Panagiotis Pontikis, MD||AstraZeneca Greece|